MarketBeat's profile
Blog
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors
Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and improving earnings. The problem: mid-single-digit gains still lagged tech
Procter & Gamble Confirms a Bottom—Time to Start Compounding?
Procter & Gamble (NYSE: PG) confirmed a bottom in early 2026, with its stock price set to advance significantly over the coming years.
Trading at long-term lows, the market had priced in the
The Hot Dog Hedge: Smithfield Acquires Nathan’s Famous
For companies that have recently returned to the public markets, the first major acquisition is a defining moment. It signals to investors exactly how management intends to use its capital to
What’s the Best Way to Buy Gold in 2026?
Many of the themes that pushed stocks higher in 2025 are back in focus to begin 2026. One of those is the bull market for precious metals. Many eyes are on silver, which has hit an all-time high
Is Abbott’s January Pullback a Good Time to Buy?
Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a